Digital Checkup (567)

AI has shaken the industry, but it’s hard to understand how patient data is being collected and used, says Sara Shanti, a partner in Sheppard Mullin’s Corporate Practice Group in Chicago.

Jay Rughani, investment partner at a16z, discusses the paper he and his colleagues recently released titled "AI: The Teammate Clinicians Need" and steps regulators should take toward reimbursement policies for care providers using the technology.

Precision medicine moved beyond chronic care into long-term care – preventing falls and reducing polypharmacy lists – while precision oncology advancements and broader payment will drive further adoption, says Dr. Joel Diamond, CMO of Aranscia.

Utilization has dropped to 5.4% of medical claims since telehealth use skyrocketed during the pandemic, says Steven Ullman, director at the Center for Health Management and Policy at the University of Miami.

Naomi Fried, founder and CEO of PharmStars, discusses the organization's 5th cohort, which is titled "Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface," and the 11 startups graduated from the accelerator program.

Dr. Michael Howell, chief clinical officer at Google, discusses the evolution of the company's medically tuned LLM, how AI can improve health equity and recommendations for regulators constructing rules around AI use in healthcare.

AI can make precision medicine more inclusive, but regulations haven't caught up, says IQVIA's Updesh Dosanjh. He explains how the digital twins developer brings humans into artificial intelligence models to maintain fairness.

Bringing telehealth and other tools into the doctor’s office increases access and destigmatizes mental health conditions, says Dr. Nele Jessel, chief medical officer at athenahealth.

Discussion of how this can be, and how healthcare can increase adoption of AI with appropriate guardrails in place for safety, transparency and ethics, from Peter Shen, head of the digital and automation business at Siemens Healthineers.

Pauliina Ilmonen, mathematician at Aalto University in Finland, discusses a project she and her colleagues are working on emulating a zombie plague to garner insights into how a major event like a pandemic or mass disinformation can spread.

Dr. Atta Behfar, CEO and cofounder of Rion, discusses the company's collaboration with Mayo Clinic and the U.S. Army Medical Research Institute thanks to a $2.4 million grant from the DoD to study Rion's Exosome Product for service members.

Sumit Rana discusses how artificial intelligence is helping providers generate progress notes, respond to patients' questions and assist with medical coding. And shows how AI sometimes can be more empathetic than humans.